Andres Liivak, a life sciences lawyer focused on health technology transactions, has joined Norton Rose Fulbright as a partner. At Kaye Scholer, he co-chaired its life sciences industry group and advised global pharmaceutical companies as well as biotechnology, medical device and other health technology concerns, Andres’ transactions practice focuses on complex collaborations, mergers and acquisitions, licensing and commercial arrangements. Andres also counsels clients on contentious transactional matters, including complex settlements of commercial and intellectual property disputes involving health technology.
